221 related articles for article (PubMed ID: 7441089)
1. Biological properties of aspartame. I. Evaluation of central nervous system effects.
Potts WJ; Bloss JL; Nutting EF
J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
[TBL] [Abstract][Full Text] [Related]
2. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
[TBL] [Abstract][Full Text] [Related]
3. The biological properties of aspartame. V. Effects on a variety of physiological parameters related to inflammation and metabolism.
Aspinall RL; Saunders RN; Pautsch WF; Nutting EF
J Environ Pathol Toxicol; 1980; 3(5-6):387-95. PubMed ID: 6108346
[TBL] [Abstract][Full Text] [Related]
4. The biological properties of aspartame. III. Examination for endocrine-like activities.
Saunders FJ; Pautsch WF; Nutting EF
J Environ Pathol Toxicol; 1980; 3(5-6):363-73. PubMed ID: 7441091
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
[TBL] [Abstract][Full Text] [Related]
6. Aspartame: effects on learning, behavior, and mood.
Saravis S; Schachar R; Zlotkin S; Leiter LA; Anderson GH
Pediatrics; 1990 Jul; 86(1):75-83. PubMed ID: 1694294
[TBL] [Abstract][Full Text] [Related]
7. Use of aspartame in pregnancy.
Sturtevant FM
Int J Fertil; 1985; 30(1):85-7. PubMed ID: 2862125
[TBL] [Abstract][Full Text] [Related]
8. Administration of aspartame in non-insulin-dependent diabetics.
Stern SB; Bleicher SJ; Flores A; Gombos G; Recitas D; Shu J
J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296
[TBL] [Abstract][Full Text] [Related]
9. Central action of glucagon.
Morawska D; Sieklucka-Dziuba M; Kleinrok Z
Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
[TBL] [Abstract][Full Text] [Related]
10. Central nervous effects of a new tricyclic antidepressant (amitriptylinoxide).
Wenzl H; Graf E; Sieck A
Arzneimittelforschung; 1978; 28(10b):1874-9. PubMed ID: 261811
[TBL] [Abstract][Full Text] [Related]
11. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
[TBL] [Abstract][Full Text] [Related]
12. No change in spontaneous behavior of rats after acute oral doses of aspartame, phenylalanine, and tyrosine.
Mullenix PJ; Tassinari MS; Schunior A; Kernan WJ
Fundam Appl Toxicol; 1991 Apr; 16(3):495-505. PubMed ID: 1677339
[TBL] [Abstract][Full Text] [Related]
13. The anti-edema activity of various naturally occurring cannabinoids.
Sofia RD; Knobloch LC; Vassar HB
Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):909-18. PubMed ID: 4760897
[No Abstract] [Full Text] [Related]
14. The biological properties of aspartame. II. Actions involving the gastrointestinal system.
Bianchi RG; Muir ET; Cook DL; Nutting EF
J Environ Pathol Toxicol; 1980; 3(5-6):355-62. PubMed ID: 6777445
[TBL] [Abstract][Full Text] [Related]
15. Stereostructure-activity relationships for oxazepam hemisuccinate. Effects on central nervous system.
de Angelis L; Predominato M; Vertua R
Arzneimittelforschung; 1972 Aug; 22(8):1328-33. PubMed ID: 4678394
[No Abstract] [Full Text] [Related]
16. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
[TBL] [Abstract][Full Text] [Related]
17. Aspartame: assessment of developmental psychotoxicity of a new artificial sweetener.
Brunner RL; Vorhees CV; Kinney L; Butcher RE
Neurobehav Toxicol; 1979; 1(1):79-86. PubMed ID: 551307
[No Abstract] [Full Text] [Related]
18. Effects of aspartame and phenylalanine on meal-time food intake of humans.
Anderson GH; Leiter LA
Appetite; 1988; 11 Suppl 1():48-53. PubMed ID: 3056266
[TBL] [Abstract][Full Text] [Related]
19. Animal experiments on the safety pharmacology of lofexidine.
Graf E; Sieck A; Wenzl H; Winkelmann J
Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute aspartame and acute alcohol ingestion upon the cognitive performance of pilots.
Stokes AF; Belger A; Banich MT; Taylor H
Aviat Space Environ Med; 1991 Jul; 62(7):648-53. PubMed ID: 1898300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
